Pali Shah is a Respiratory physician affiliated with Johns Hopkins University. OpenAlex indexes 197 publications with 4,772 citations (h-index 37); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial
Sponsor: Johns Hopkins University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
34%Loop diuretic16%Furosemide100%Part D<11 patientsStatin10.5%Rosuvastatin Calcium100%Part D<11 patients+ 1 more class in this area
Anti-infectives
30.9%Macrolide Antimicrobial17.3%Azithromycin100%Part D<11 patientsShort-acting sulfonamides13.6%Sulfamethoxazole-Trimethoprim100%Part D<11 patientsMetabolism & gastrointestinal
25.9%Corticosteroid19.1%Prednisone100%Part D≥16 patientsH2 blocker6.8%Famotidine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial
American Journal of Respiratory and Critical Care Medicine
2024 - Early United States experience with lung donation after circulatory death using thoracoabdominal normothermic regional perfusion
The Journal of Heart and Lung Transplantation
2023 - Contemporary trends in PGD incidence, outcomes, and therapies
The Journal of Heart and Lung Transplantation
2022 - Wnt activation promotes memory T cell polyfunctionality via epigenetic regulator PRMT1
Journal of Clinical Investigation
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Laheru, MD
Johns Hopkins University
Demosthenes G. Katritsis
Johns Hopkins University
Tanguy Seiwert, MD
Johns Hopkins University
Evan Lipson, MD
Johns Hopkins University
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”